Enrichment of these types of mutations in XP-V suggests that they might originate from lesions that are bypassed by polymerase η in an error-free manner in sporadic skin cancer, but XP-V cells have to use an alternative polymerase(s) to bypass these lesions. The gene discussed is POLH; the disease is skin cancer.